Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Mary Jeanne Kreek, M.D. Patrick E. and Beatrice M. Haggerty Professor - ppt download
Biomedicines | Free Full-Text | Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders | HTML
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
The molecular neurobiology and neuropathology of opioid use disorder - ScienceDirect
Stress and opioids: Role of opioids in modulating stress-related behavior and effect of stress on morphine conditioned place preference - ScienceDirect
Stress and opioids: Role of opioids in modulating stress-related behavior and effect of stress on morphine conditioned place preference - ScienceDirect
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Buprenorphine: A Promising Yet Overlooked Tool
PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization | Journal of Neuroscience
Κ-opioid receptor - an overview | ScienceDirect Topics
Buprenorphine: A Promising Yet Overlooked Tool
κ-opioid receptor - Wikipedia
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC
The molecular neurobiology and neuropathology of opioid use disorder - ScienceDirect
Κ-opioid receptor - an overview | ScienceDirect Topics
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
